Switzerland-based drugs company Debiopharm Group has acquired a minority equity stake in local electronic marketing platform Tweasy for an undisclosed amount. José de Bastos, chief executive of Tweasy, said: “Thanks to the Debiopharm Group, we will be able to graduate from the incubation period and accelerate our development. In practical terms, we are going to…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.